The cumulative hepatocarcinogenesis rate of 238 Japanese NAFLD patients diagnosed by biopsy was examined in PNPLA3 SNP [20]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.